Evidence map›Paper›PMID 28325855›Full record

ArticleClinical science (London, England : 1979)2017

Pretreatment with the ALDH2 agonist Alda-1 reduces intestinal injury induced by ischaemia and reperfusion in mice.

Qiankun Zhu, Guizhen He, Jie Wang, Yukang Wang, Wei Chen

Open access · hybridAbstract read
In one paragraph

Article in Clinical science (London, England : 1979), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Metabolites · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Targeting liver aldehyde dehydrogenase-2 prevents heavy but not moderate alcohol drinking.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Qiankun ZhuDepartment of Parenteral and Enteral Nutrition, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, 100730, China.
Guizhen HeDepartment of Parenteral and Enteral Nutrition, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, 100730, China hgzpumc@163.com.
Jie WangDepartment of Parenteral and Enteral Nutrition, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, 100730, China.
Yukang WangDepartment of Parenteral and Enteral Nutrition, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, 100730, China.
Wei ChenDepartment of Parenteral and Enteral Nutrition, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, 100730, China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNPeking Union Medical College Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many studies demonstrate that activation of aldehyde dehydrogenase 2 (ALDH2) protects against oxidative stress via detoxification of cytotoxic aldehydes, and could attenuate cardiac, cerebral, lung and renal ischaemia-reperfusion (I/R) injuries. However, the effect of ALDH2 in intestinal I/R is unknown. The present study was set up to determine whether an ALDH2 agonist, Alda-1, could alleviate intestinal injury after gut I/R. In a mouse model of intestinal I/R injury, histological grading, proinflammatory cytokines, oxidative stress, cellular apoptosis, chemokine contents, ALDH2 activity, 4-hydroxy-

Indexed as

Aldehyde Dehydrogenase, MitochondrialAldehydesAnimalsApoptosisBenzamidesBenzodioxolesChemokinesCytokinesDrug Evaluation, PreclinicalEnzyme ActivationInflammation MediatorsIntestinal DiseasesLung DiseasesMaleMice, Inbred C57BLOxidative StressAldehyde Dehydrogenase, MitochondrialAldehydesALDH2 protein, mouseBenzamidesBenzodioxolesChemokinesCytokinesInflammation MediatorsN-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamideTlr4 protein, mouseToll-Like Receptor 44-hydroxy-trans-2-nonenalAlda-1ALDH2intestineischaemia–reperfusion injurymultiple organ dysfunction syndrome

Identifiers

PMID28325855
PMCPMC5434792
OpenAlexW2601141785

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.